Quarterly report [Sections 13 or 15(d)]

Significant Accounting Policies and Estimates (Tables)

v3.26.1
Significant Accounting Policies and Estimates (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents

 Schedule of Cash and Cash Equivalents

    March 31,     March 31,  
    2026     2025  
Cash   $ 208     $ 1,192  
Restricted cash     1,914       -  
Total cash and restricted cash shown in the statement of cash flows   $ 2,122     $ 1,192  
Schedule of Disaggregated Revenue by Sales Type

Disaggregated revenue by sales type ($ in thousands):

 

         
    Three Months Ended  
    March 31,  
    2026     2025  
Contract manufacturing   $ 916     $ 948  
Custom and white label finished goods manufacturing     -       -  
Consumer branded products     1,621       1,782  
Medical devices/other     113       76  
Total   $ 2,650     $ 2,806